Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Mania in Bipolar Disorder”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Study completedNCT00488618
What this trial is testing

Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania

Who this might be right for
Bipolar Disorder
Forest Laboratories 238
Large-scale testing (Phase 3)Study completedNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 351
Testing effectiveness (Phase 2)Study completedNCT00001483
What this trial is testing

Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

Who this might be right for
Bipolar DisorderDepressive Disorder
National Institute of Mental Health (NIMH) 75
Large-scale testing (Phase 3)Study completedNCT03287869
What this trial is testing

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Who this might be right for
Bipolar I DisorderAcute Mania
Otsuka Pharmaceutical Development & Commercialization, Inc. 381
Large-scale testing (Phase 3)Study completedNCT01059539
What this trial is testing

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Forest Laboratories 403
Large-scale testing (Phase 3)Study completedNCT00145470
What this trial is testing

12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)

Who this might be right for
Bipolar Disorder
Organon and Co 326
Large-scale testing (Phase 3)Study completedNCT00095511
What this trial is testing

Aripiprazole in Patients With Acute Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 615
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Study completedNCT00035802
What this trial is testing

Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Large-scale testing (Phase 3)Study completedNCT00097266
What this trial is testing

Study of Aripiprazole in Patients With Acute Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 615
Large-scale testing (Phase 3)Study completedNCT04819776
What this trial is testing

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Vanda Pharmaceuticals 417
Large-scale testing (Phase 3)Study completedNCT00312494
What this trial is testing

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 680
Large-scale testing (Phase 3)Study completedNCT00143182
What this trial is testing

9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

Who this might be right for
Bipolar Disorder
Organon and Co 504
Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing

Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493
Large-scale testing (Phase 3)Study completedNCT01349907
What this trial is testing

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Who this might be right for
Bipolar Disorder
Organon and Co 322
Post-approval studies (Phase 4)Study completedNCT00350857
What this trial is testing

The Young Adult and Pediatric Bipolar Study

Who this might be right for
Bipolar I Disorder
Validus Pharmaceuticals 161
Not applicableStudy completedNCT00690248
What this trial is testing

Depressive Symptoms in Acute Manic Episode

Who this might be right for
Bipolar Disorder
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT00076115
What this trial is testing

Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Post-approval studies (Phase 4)Not Yet RecruitingNCT07665073
What this trial is testing

Risperidone vs Cariprazine in Acute Mania

Who this might be right for
Bipolar 1 Disorder
Pakistan Institute of Medical Sciences 50
Post-approval studies (Phase 4)Study completedNCT00545142
What this trial is testing

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

Who this might be right for
Bipolar Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 280
Next Page